EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Research progress of m6A methylation in prostate cancer

Shou-Yi Zhang, Yu Zeng

Asian Journal of Andrology · 2023

DOI: 10.4103/aja202265 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Asian Journal of Andrology, 2023. Verfasst von Shou-Yi Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang 110042, China. Hauptthemen laut MEDLINE: Adenosine, Prostatic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N 6 -methyladenosine (m 6 A) is a ubiquitous RNA modification in mammals. This modification is “written” by methyltransferases and then “read” by m 6 A-binding proteins, followed by a series of regulation, such as alternative splicing, translation, RNA stability, and RNA translocation. At last, the modification is “erased” by demethylases. m 6 A modification is essential for normal physiological processes in mammals and is also a very important epigenetic modification in the development of cancer. In recent years, cancer-related m 6 A regulation has been widely studied, and various mechanisms of m 6 A regulation in cancer have also been recognized. In this review, we summarize the changes of m 6 A modification in prostate cancer and discuss the effect of m 6 A regulation on prostate cancer progression, aiming to profile the potential relevance between m 6 A regulation and prostate cancer development. Intensive studies on m 6 A regulation in prostate cancer may uncover the potential role of m 6 A methylation in the cancer diagnosis and cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineProstatic NeoplasmsAnimalsMaleHumansMethylationRNAMethyltransferasesMammals

Stichwörter der Autor:innen

N6-methyladenosine methylationepigeneticmolecular biologyprostate cancer

Substanzen

AdenosineRNAMethyltransferases

Autor:innen und Institutionen

  • Department of Urology, The Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang 110042, China.

Zitieren

APA

Zhang, S. Y., & Zeng, Y. (2023). Research progress of m6A methylation in prostate cancer. Asian Journal of Andrology. https://doi.org/10.4103/aja202265

Vancouver

Zhang SY, Zeng Y. Research progress of m6A methylation in prostate cancer. Asian Journal of Andrology. 2023. doi:10.4103/aja202265

BibTeX
@article{Zhang2023,
  author = {Zhang, Shou-Yi and Zeng, Yu},
  title = {Research progress of m6A methylation in prostate cancer},
  journal = {Asian Journal of Andrology},
  year = {2023},
  doi = {10.4103/aja202265}
}
Kostenlos starten →